Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HS-10510 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics of HS-10510 in healthy subjects for potential dyslipidemia treatment; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• HS-10510

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Dyslipidemia | Phase 1 | Status: NOT_YET_RECRUITING